9 October 2008 in Journal of Northwest Atlantic Fishery Science
Tanner crab (Chionoecetes bairdi) in the eastern Bering Sea are primarily distributed in Bristol Bay and around the Pribilof Islands. Summer trawl survey data in these two areas were used to estimate mean sizes at maturity for female Tanner crab from 1975 to 2006 and sizes at 50% morphometric maturity for male Tanner crab from 1990 to 2006. Estimated mean sizes at maturity for females showed a statistically significant downward trend in both areas. Sizes at 50% morphometric maturity for males have declined significantly since 1990, in Bristol Bay only. In Bristol Bay, the distribution centers of female Tanner crab have shifted southwest over time and the decrease in female mean size at maturity was significantly related to changes in longitude and bottom depths. Because of terminal molt at maturity, the decrease in size at maturity has important implications for fisheries management: under the current size limit, a smaller proportion of males grow to legal size and therefore a higher proportion of large-growing males are removed by the fishery be- fore they have a chance to participate in reproduction. With the recent maturity at a small size, reduction of the current harvest rates and size limit while maintaining current fishing gear requirements will result in higher yield and higher male spawning biomass per recruit than those under the current harvest strategy.
24 September 2025 in Cancer Research
Mental stress is widely recognized as a significant risk factor for breast cancer, exerting detrimental effects on both progression and prognosis. Herein, we investigated the role of stress in regulating breast cancer metastasis. In genetically engineered and transplantation breast cancer mouse models, chronic stress stimulation increased tumor growth and lung metastasis. Single-cell RNA sequencing analysis of the premetastatic lung microenvironment revealed induction of a previously unrecognized subtype of cancer stress–primed (CSP) neutrophils, characterized by the overexpression of Ccl3, Ccl4, Cxcl2, Il1r2, and Cebpb. Pseudotime trajectory analysis demonstrated that chronic stress caused a shift of neutrophils from the cancer-primed neutrophil subtype to the CSP subtype in the lung. Activation of the glucocorticoid receptor NR3C1 by the stress hormone corticosterone induced expression of Cebpb in neutrophils, which then promoted transcription of Ccl3 and Ccl4. The differentiation of neutrophils into the CSP subtype promoted lung metastasis of CCR1+ breast cancer cells via CCL3/CCL4-mediated recruitment. Targeting this axis using an anti-Ly6G antibody to deplete neutrophils, a CRISPR/Cas9-mediated approach to conditionally knock out Ccl3/Ccl4 in neutrophils, and BX471 treatment to inhibit CCR1 in cancer cells all significantly reduced breast cancer lung metastasis. Together, this study not only demonstrates a stress–neutrophil–cancer axis that promotes lung metastasis in breast cancer but also provides potential strategies for reducing lung metastasis by targeting CSP neutrophils or CCR1+ breast cancer cells. Significance: Stress induces a neutrophil subtype in the lungs that secretes CCL3 and CCL4 to stimulate metastasis of breast cancer cells by activating CCR1, offering potential strategies for preventing or treating metastasis.
22 June 2022 in Microbial Genomics
Emerging evidence has identified viral circular RNAs (circRNAs) in human cells infected by viruses, interfering with the immune system and inducing diseases including human cancer. However, the biogenesis and regulatory mechanisms of virus-encoded circRNAs in host cells remain unknown. In this study, we used the circRNA detection tool CIRI2 to systematically determine the virus-encoded circRNAs in virus-infected cancer cell lines and cancer patients, by analysing RNA-Seq datasets derived from RNase R-treated samples. Based on the thousands of viral circRNAs we identified, the biological characteristics and potential roles of viral circRNAs in regulating host cell function were determined. In addition, we developed a Viral-circRNA Database (http://www.hywanglab.cn/vcRNAdb/), which is open to all users to search, browse and download information on circRNAs encoded by viruses upon infection.
19 November 2024 in Advanced Science
Intratumour heterogeneity significantly hinders the efficacy of anticancer therapies. Compared with drug perturbation experiments, which yield pharmacological data at the bulk cell level, single‐cell RNA sequencing (scRNA‐seq) technology provides a means to capture molecular heterogeneity at single‐cell resolution. Here, scPharm is introduced, a computational framework that integrates pharmacological profiles with scRNA‐seq data to identify pharmacological subpopulations of cells within a tumour and prioritize tailored drugs. scPharm uses the normalized enrichment scores (NESs) determined from gene set enrichment analysis to assess the distribution of cell identity genes in drug response‐determined gene lists. Based on the strong correlation between the NES and drug response at single‐cell resolution, scPharm successfully identified the sensitive subpopulations in ER‐positive and HER2‐positive human breast cancer tissues, revealed dynamic changes in the resistant subpopulation of human PC9 cells treated with erlotinib, and expanded its ability to a mouse model. Its superior performance and computational efficiency are confirmed through comparative evaluations with other single‐cell prediction tools. Additionally, scPharm predicted combination drug strategies by gauging compensation or booster effects between drugs and evaluated drug toxicity in healthy cells in the tumour microenvironment. Overall, scPharm provides a novel approach for precision medicine in cancers by revealing therapeutic heterogeneity at single‐cell resolution.